Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1

Status

Completed 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Liver Neoplasms 1Breast Cancer Patient 1Brain Neoplasms 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Pregabalin × 90 days × Clear all
NCT07630753 2026-06-05

Effect of Pregabalin on Optic Nerve Sheath Diameter in Craniotomy Patients.

Benha University

Phase NA Active not recruiting
100 enrolled
CNS

Brain Neoplasms

NCT07606638 2026-05-26

Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients

Mayo Hospital Lahore

Phase NA Enrolling by invitation
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT03794388 2026-05-05

CAPTRANE

Institut Cancerologie de l'Ouest

Phase 3 Completed
140 enrolled 6 charts
Breast

Breast Cancer Patient

NCT03151213 2026-03-13

pregabalin

Tanta University

Phase 4 Completed
70 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡